IGF1 and prostate carcinoma: A number of observational studies have consistently reported positive associations of circulating IGF‐I with prostate cancer, but inferences of causality are limited with observational studies.3, 4, 36 MR is designed to overcome these problems if the exposure is adequately instrumented.